Utama › Kanser Metastatik › Rhode Island › Providence
Kajian klinikal Kanser Metastatik di Providence, RI
9 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Providence (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
- Women and Infants Hospital, Providence
- Roger Williams Medical Center, Providence
TLR9 Immunotherapy for Peritoneal Carcinomatosis
Mengambil pesertaFasa 1
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Rhode Island Hospital, Providence
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Mengambil pesertaFasa 3
- Research Site, Providence
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Mengambil pesertaFasa 3
- Women & Infants Hospital, Providence
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Lifespan Cancer Institute, Providence
A Study of PYX-201 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Rhode Island Hospital, Providence
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Mengambil pesertaFasa 1/2
- Brown University Health Cancer Institute, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Providence
Kajian Kanser Metastatik di bandar lain
- Houston, TX104 kajian
- New York City, NY93 kajian
- Nashville, TN70 kajian
- Boston, MA63 kajian
- Los Angeles, CA57 kajian
- St. Louis, MO54 kajian
- Arlington, VA53 kajian
- Philadelphia, PA46 kajian
- Chicago, IL45 kajian
- San Antonio, TX44 kajian
- Washington, DC43 kajian
- Dallas, TX42 kajian
Kajian lain di Providence
- Kanser Ovari15 kajian
- Kanser Endometrium14 kajian
- Obesiti14 kajian
- Kanser Paru-paru Bukan Sel Kecil12 kajian
- Kanser (semua jenis)12 kajian
- Penyakit Crohn12 kajian
- Kolitis Ulseratif11 kajian
- Kanser Payudara11 kajian
- Leukemia Mieloid Akut10 kajian
- Berat Badan Berlebihan9 kajian
- Penyakit Alzheimer8 kajian
- Gangguan Penggunaan Alkohol (AUD)8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.